Dr. Alexander Khoruts and his research team published a study in the Journal of Clinical Oncology demonstrating the safety of using microbiota transplant therapy (MTT) in patients with acute myeloid leukemia (AML) and recipients of hematopoietic cell transplantation (HCT). These promising results lay the groundwork for larger studies to develop safer treatment options for patients with AML and HCT that are less damaging to their immune system and intestinal lining. READ MORE>>